Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Seufferlein

Showing results (251-260 of 367) with videos related to

Pageof 37
Sort By:
Zeitschrift Fur Gastroenterologie|June 7, 2022
Thomas Seufferlein, Julia Mayerle, Stefan Böck, et al.
Zeitschrift Fur Gastroenterologie|October 10, 2024
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Zeitschrift Fur Gastroenterologie|October 10, 2024
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Frontiers in Oncology|February 2, 2023
Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastasesLaura Uder, Marcel Nachbar, Sarah Butzer, et al.
Communications Biology|November 18, 2021
Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiationSandra Heller, Zhijian Li, Qiong Lin, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Thomas Seufferlein, Julia Mayerle, Stefan Böck, et al.
United European Gastroenterology Journal|December 2, 2022
UEG position paper: Obesity and digestive healthPatrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, et al.
BMC Cancer|May 28, 2009
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2Angela Märten, Jan Schmidt, Jennifer Ose, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rashMichael Steffens, Tanusree Paul, Vivien Hichert, et al.
Zeitschrift Fur Gastroenterologie|May 27, 2025
[Correction: AWMF-Registernummer: 032-010OL - Leitlinie (Kurzversion)]Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Pageof 37

Showing results (251-260 of 367) with videos related to

Sort By:
Pageof 37
Zeitschrift Fur Gastroenterologie|June 7, 2022
Thomas Seufferlein, Julia Mayerle, Stefan Böck, et al.
Zeitschrift Fur Gastroenterologie|October 10, 2024
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Zeitschrift Fur Gastroenterologie|October 10, 2024
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Frontiers in Oncology|February 2, 2023
Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastasesLaura Uder, Marcel Nachbar, Sarah Butzer, et al.
Communications Biology|November 18, 2021
Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiationSandra Heller, Zhijian Li, Qiong Lin, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Thomas Seufferlein, Julia Mayerle, Stefan Böck, et al.
United European Gastroenterology Journal|December 2, 2022
UEG position paper: Obesity and digestive healthPatrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, et al.
BMC Cancer|May 28, 2009
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2Angela Märten, Jan Schmidt, Jennifer Ose, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rashMichael Steffens, Tanusree Paul, Vivien Hichert, et al.
Zeitschrift Fur Gastroenterologie|May 27, 2025
[Correction: AWMF-Registernummer: 032-010OL - Leitlinie (Kurzversion)]Thomas Seufferlein, Julia Mayerle, Stefan Boeck, et al.
Pageof 37